Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 2/2004

01-02-2004 | Original Article

Heterogeneity of cerebral blood flow in frontotemporal lobar degeneration and Alzheimer’s disease

Authors: Michinobu Nagao, Yoshifumi Sugawara, Manabu Ikeda, Ryuji Fukuhara, Kazuhiko Hokoishi, Kenya Murase, Teruhito Mochizuki, Hitoshi Miki, Takanori Kikuchi

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 2/2004

Login to get access

Abstract

This study was designed to quantify the heterogeneity on cerebral blood flow single-photon emission tomography (SPET) images in frontotemporal lobar degeneration (FTLD) and Alzheimer’s disease (AD) using a three-dimensional fractal analysis. Twenty-one FTLD patients, 21 AD patients and 11 healthy controls underwent technetium-99m hexamethylpropylene amine oxime SPET scanning. Patients with FTLD and AD matched for sex, age and the severity of dementia as estimated with the Clinical Dementia Rating and were determined to be in the early stage of illness. We delineated the SPET images using a 35% cut-off and a 50% cut-off of the maximal voxel radioactivity and measured the number of voxels included in the contours of two different cut-offs. The fractal dimension (FD) was calculated by relating the logarithms of the cut-offs and the numbers of voxels, and it was defined as the heterogeneity of the cerebral perfusion. We divided the SPET images into two sets, anterior and posterior, with equal numbers of coronal SPET slices. We calculated total FD, anterior FD and posterior FD for total, anterior and posterior SPET images. Anterior FDs for FTLD and AD were 1.55±0.34 and 1.24±0.19 (P=0.0002). The ratios of anterior to posterior FD for FTLD and AD were 1.81±0.41 and 1.32±0.14 (P<0.0001). Use of the anterior FD and the ratio of anterior to posterior FD separated FTLD patients from AD patients and controls with a sensitivity of 85.7% and a specificity of 93.8%. Anterior FD and the ratio of anterior to posterior FD may be useful in distinguishing FTLD from AD.
Literature
1.
go back to reference Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51:1546–1554.PubMed Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51:1546–1554.PubMed
2.
go back to reference The Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994; 57:416–418.PubMed The Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994; 57:416–418.PubMed
3.
go back to reference Knopman DS, Mastri AR, Frey WH, Sung JH, Rustan BA. Dementia lacking distinctive histologic feature: a common non-Alzheimer degenerative dementia. Neurology 1990; 40:251–256.PubMed Knopman DS, Mastri AR, Frey WH, Sung JH, Rustan BA. Dementia lacking distinctive histologic feature: a common non-Alzheimer degenerative dementia. Neurology 1990; 40:251–256.PubMed
4.
go back to reference Gustafson L. Clinical picture of frontal lobe degeneration of non-Alzheimer type. Dementia 1993; 4:143–148.PubMed Gustafson L. Clinical picture of frontal lobe degeneration of non-Alzheimer type. Dementia 1993; 4:143–148.PubMed
5.
go back to reference Neary D, Snowden JS, Northen B, Goulding P. Dementia of the frontal lobe type. J Neurol Neurosurg Psychiatry 1988; 51:353–361.PubMed Neary D, Snowden JS, Northen B, Goulding P. Dementia of the frontal lobe type. J Neurol Neurosurg Psychiatry 1988; 51:353–361.PubMed
6.
go back to reference Miller BL, Cummings JL, Villanueva-Meyer J, et al. Frontal lobe degeneration: clinical, neuropsychological, and SPECT characteristics. Neurology 1991; 41:1347–1382. Miller BL, Cummings JL, Villanueva-Meyer J, et al. Frontal lobe degeneration: clinical, neuropsychological, and SPECT characteristics. Neurology 1991; 41:1347–1382.
7.
go back to reference Launes J, Sulkava R, Erkinjuntti T, et al. Technetium-99m HMPAO SPECT in suspected dementia. Nucl Med Commun 1991; 12:757–765.PubMed Launes J, Sulkava R, Erkinjuntti T, et al. Technetium-99m HMPAO SPECT in suspected dementia. Nucl Med Commun 1991; 12:757–765.PubMed
8.
go back to reference Minoshima S, Giordani B, Frey KA, et al. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer’s disease. Ann Neurol. 1997; 42:85–94. Minoshima S, Giordani B, Frey KA, et al. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer’s disease. Ann Neurol. 1997; 42:85–94.
9.
go back to reference Imran MB, Kawashima R, Awata S, et al. Parametric mapping of cerebral blood flow deficits in Alzheimer’s disease: a SPECT study using HMPAO and image standardization technique. J Nucl Med 1999; 40:244–249.PubMed Imran MB, Kawashima R, Awata S, et al. Parametric mapping of cerebral blood flow deficits in Alzheimer’s disease: a SPECT study using HMPAO and image standardization technique. J Nucl Med 1999; 40:244–249.PubMed
10.
go back to reference Holman BL, Johnson KA, Gerada B, et al. The scintigraphic appearance of Alzheimer’s disease: a prospective study using Tc-99m HMPAO SPECT. J Nucl Med 1992; 33:181–185.PubMed Holman BL, Johnson KA, Gerada B, et al. The scintigraphic appearance of Alzheimer’s disease: a prospective study using Tc-99m HMPAO SPECT. J Nucl Med 1992; 33:181–185.PubMed
11.
go back to reference Messa C, Perani D, Lucignani G, et al. High-resolution technetium-99m HMPAO SPECT in patients with probable Alzheimer’s disease: comparison with fluorine-18-FDG-PET. J Nucl Med 1994; 35:210–216.PubMed Messa C, Perani D, Lucignani G, et al. High-resolution technetium-99m HMPAO SPECT in patients with probable Alzheimer’s disease: comparison with fluorine-18-FDG-PET. J Nucl Med 1994; 35:210–216.PubMed
12.
go back to reference Ohnishi T, Hoshi H, Nagamachi R, et al. High-resolution SPECT to assess hippocampal perfusion in neuropsychiatric diseases. J Nucl Med 1995; 36:1163–1169.PubMed Ohnishi T, Hoshi H, Nagamachi R, et al. High-resolution SPECT to assess hippocampal perfusion in neuropsychiatric diseases. J Nucl Med 1995; 36:1163–1169.PubMed
13.
go back to reference Gustafson L. Frontal lobe degeneration of non-Alzheimer type. Clinical picture and differential diagnosis. Arch Gerontol Geriatr 1987; 6:209–223.PubMed Gustafson L. Frontal lobe degeneration of non-Alzheimer type. Clinical picture and differential diagnosis. Arch Gerontol Geriatr 1987; 6:209–223.PubMed
14.
go back to reference Holman BL, Devous MD Sr. Functional brain SPECT: the emergence of a powerful clinical method. J Nucl Med 1992; 33:1888–1904.PubMed Holman BL, Devous MD Sr. Functional brain SPECT: the emergence of a powerful clinical method. J Nucl Med 1992; 33:1888–1904.PubMed
15.
go back to reference Pickut BA, Saerens J, Marien P, et al. Discriminative use of SPECT in frontal lobe-type dementia versus (senile) dementia of the Alzheimer’s type. J Nucl Med 1997; 38: 929–934.PubMed Pickut BA, Saerens J, Marien P, et al. Discriminative use of SPECT in frontal lobe-type dementia versus (senile) dementia of the Alzheimer’s type. J Nucl Med 1997; 38: 929–934.PubMed
16.
go back to reference Nagao M, Murase K, Kikuchi T, et al. Fractal analysis of cerebral blood flow distribution in Alzheimer’s disease. J Nucl Med 2001; 42:1446–1450.PubMed Nagao M, Murase K, Kikuchi T, et al. Fractal analysis of cerebral blood flow distribution in Alzheimer’s disease. J Nucl Med 2001; 42:1446–1450.PubMed
17.
go back to reference Hokoishi K, Ikeda M, Maki N, et al. Frontotemporal lobar degeneration: a study in Japan. Dement Geriatr Cogn Disord 2001; 12:393–399.CrossRefPubMed Hokoishi K, Ikeda M, Maki N, et al. Frontotemporal lobar degeneration: a study in Japan. Dement Geriatr Cogn Disord 2001; 12:393–399.CrossRefPubMed
18.
go back to reference Folstein MF, Folstein SE, McHugh PR. Mini-Mental State. A practical method for grading the cognitive state of patients for clinician. J Psychiat Res 1975; 12:189–198.CrossRefPubMed Folstein MF, Folstein SE, McHugh PR. Mini-Mental State. A practical method for grading the cognitive state of patients for clinician. J Psychiat Res 1975; 12:189–198.CrossRefPubMed
19.
go back to reference Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer’s disease. Am J Psychiatry 1984; 141:1356–1364.PubMed Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer’s disease. Am J Psychiatry 1984; 141:1356–1364.PubMed
20.
go back to reference Morris JC. The Clinical Dementia Rating (CDR): current version and screening rules. Neurology 1993; 43:2412–2414. Morris JC. The Clinical Dementia Rating (CDR): current version and screening rules. Neurology 1993; 43:2412–2414.
21.
go back to reference McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984; 34:939–944.PubMed McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984; 34:939–944.PubMed
22.
go back to reference Mandelbrot B. How long is the coast of Britain? Statistical self-similarity and fractal dimension. Science 1967; 156:636–638. Mandelbrot B. How long is the coast of Britain? Statistical self-similarity and fractal dimension. Science 1967; 156:636–638.
23.
go back to reference Nelson T. Fractal physiologic complexity, scaling, and opportunities for imaging. Invest Radiol 1990; 25:1140–1148.PubMed Nelson T. Fractal physiologic complexity, scaling, and opportunities for imaging. Invest Radiol 1990; 25:1140–1148.PubMed
24.
go back to reference Chung HW, Huang YH. Fractal analysis of nuclear medicine images for the diagnosis of pulmonary emphysema: interpretations, implications, and limitations. AJR 2000; 174:1055–1059. Chung HW, Huang YH. Fractal analysis of nuclear medicine images for the diagnosis of pulmonary emphysema: interpretations, implications, and limitations. AJR 2000; 174:1055–1059.
25.
go back to reference Nagao M, Murase K. Measurement of heterogeneous distribution on Technegas SPECT images by three-dimensional fractal analysis. Ann Nucl Med 2002; 16:369–376.PubMed Nagao M, Murase K. Measurement of heterogeneous distribution on Technegas SPECT images by three-dimensional fractal analysis. Ann Nucl Med 2002; 16:369–376.PubMed
26.
go back to reference Snowden JS, Neary D, Mann DMA. Fronto-temporal lobar degeneration: fronto-temporal dementia, progressive aphasia, sematic dementia. New York: Livingstone, 1996. Snowden JS, Neary D, Mann DMA. Fronto-temporal lobar degeneration: fronto-temporal dementia, progressive aphasia, sematic dementia. New York: Livingstone, 1996.
27.
go back to reference Ishii K, Sakamoto S, Sasaki M, et al. Cerebral glucose metabolism in patients with frontotemporal dementia. J Nucl Med 1998; 39:1875–1878.PubMed Ishii K, Sakamoto S, Sasaki M, et al. Cerebral glucose metabolism in patients with frontotemporal dementia. J Nucl Med 1998; 39:1875–1878.PubMed
28.
go back to reference Kitagaki H, Mori E, Hirono N, et al. Alteration of white matter MR signal intensity in frontotemporal dementia. Am J Neuroradiol 1997; 18:367–378.PubMed Kitagaki H, Mori E, Hirono N, et al. Alteration of white matter MR signal intensity in frontotemporal dementia. Am J Neuroradiol 1997; 18:367–378.PubMed
29.
go back to reference DeKosky ST, Harbaugh RE, Schmitt FA, et al. The Intraventricular Bethanecol Study Group: cortical biopsy in Alzheimer’s disease: diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Ann Neurol 1992; 32:625–632.PubMed DeKosky ST, Harbaugh RE, Schmitt FA, et al. The Intraventricular Bethanecol Study Group: cortical biopsy in Alzheimer’s disease: diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Ann Neurol 1992; 32:625–632.PubMed
30.
go back to reference Meyer M, Koeppe RA, Frey KA, et al. Positron emission tomography measures of benzodiazepine binding in Alzheimer’s disease. Arch Neurol 1995; 52:314–317.PubMed Meyer M, Koeppe RA, Frey KA, et al. Positron emission tomography measures of benzodiazepine binding in Alzheimer’s disease. Arch Neurol 1995; 52:314–317.PubMed
31.
go back to reference Terry RD, Peck A, Deteresa R, et al. Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol 1981; 10:184–192.PubMed Terry RD, Peck A, Deteresa R, et al. Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol 1981; 10:184–192.PubMed
32.
go back to reference Rogers J, Morrison JH. Quantitative morphology and regional and laminar distribution of senile plaques in Alzheimer’s disease. J Neurosci 1985; 5:2801–2808.PubMed Rogers J, Morrison JH. Quantitative morphology and regional and laminar distribution of senile plaques in Alzheimer’s disease. J Neurosci 1985; 5:2801–2808.PubMed
33.
go back to reference Kuikka JT, Bassingthwaighte JB, Henrich MM. Mathematical modeling in nuclear medicine. Eur J Nucl Med 1991; 18:351–361.PubMed Kuikka JT, Bassingthwaighte JB, Henrich MM. Mathematical modeling in nuclear medicine. Eur J Nucl Med 1991; 18:351–361.PubMed
34.
go back to reference Kuikka JT. Effect of tissue heterogeneity on quantification in positron emission tomography. Eur J Nucl Med 1995; 22:1457–1458.PubMed Kuikka JT. Effect of tissue heterogeneity on quantification in positron emission tomography. Eur J Nucl Med 1995; 22:1457–1458.PubMed
35.
go back to reference Yoshikawa T, Murase K, Oku N, et al. Statistical image analysis of cerebral blood flow in vascular dementia with small-vessels disease. J Nucl Med 2003; 44:505–511.PubMed Yoshikawa T, Murase K, Oku N, et al. Statistical image analysis of cerebral blood flow in vascular dementia with small-vessels disease. J Nucl Med 2003; 44:505–511.PubMed
36.
go back to reference Page MP, Howard RJ, O’Brien JT, Buxton-Thomas MS, Pickering AD. Use of neural networks in brain SPECT to diagnose Alzheimer’s disease. J Nucl Med 1996; 37:195–200.PubMed Page MP, Howard RJ, O’Brien JT, Buxton-Thomas MS, Pickering AD. Use of neural networks in brain SPECT to diagnose Alzheimer’s disease. J Nucl Med 1996; 37:195–200.PubMed
37.
go back to reference Hamilton D, O’Mahony D, Coffey J, et al. Classification of mild Alzheimer’s disease by artificial neural network analysis of SPET data. Nucl Med Commun 1997; 18:805–810.PubMed Hamilton D, O’Mahony D, Coffey J, et al. Classification of mild Alzheimer’s disease by artificial neural network analysis of SPET data. Nucl Med Commun 1997; 18:805–810.PubMed
Metadata
Title
Heterogeneity of cerebral blood flow in frontotemporal lobar degeneration and Alzheimer’s disease
Authors
Michinobu Nagao
Yoshifumi Sugawara
Manabu Ikeda
Ryuji Fukuhara
Kazuhiko Hokoishi
Kenya Murase
Teruhito Mochizuki
Hitoshi Miki
Takanori Kikuchi
Publication date
01-02-2004
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 2/2004
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-003-1343-6

Other articles of this Issue 2/2004

European Journal of Nuclear Medicine and Molecular Imaging 2/2004 Go to the issue

Letter to the Editor

Reply